Pharmacy benefit manager Capital Rx has completed its acquisition of health navigation platform Amino Health, marking a significant expansion of the company's enterprise platform capabilities. The deal brings Capital Rx's total platform capacity to nearly 60 million covered lives across its portfolio, while transforming Amino Health into Judi Care, Capital Rx's new care navigation offering.
The acquisition addresses critical challenges in healthcare navigation by combining Amino Health's established navigation platform with Capital Rx's pharmacy benefit management infrastructure. Judi Care integrates multiple healthcare touchpoints into a single platform, including provider search capabilities, appointment booking functionality, cost transparency tools, and prescription savings programs. This comprehensive approach aims to streamline the healthcare experience for plan members while providing administrators with enhanced management tools.
"Outdated technology, stale provider directories and misaligned incentives should never encumber a patient's care journey," stated AJ Loiacono, cofounder and CEO of Capital Rx. "With Judi Care's data-first, AI-driven patient navigation solution, we are bringing our clients the level of transparency and control required to engage and empower plan members to seek the best possible care when needed."
The combined offering targets a diverse client base including health plans, third-party administrators, government agencies, employers, and health systems. When integrated with Judi Health, Capital Rx's unified claims processing platform, the solution provides organizations with comprehensive tools for managing both pharmacy and medical benefits through a single system.
John Asalone, who currently serves as CEO of Amino Health, will transition to the role of executive vice president of Judi Care following the acquisition. "By integrating provider search, appointment booking, cost estimates and prescription savings into one seamless experience, we are empowering people to take control of their health," Asalone commented. "We have brought all the data together in a configurable, AI-driven platform to deliver the best navigation experience possible. Joining Capital Rx will accelerate our mission and bring the platform to millions of more members."
The acquisition builds on Amino Health's recent strategic initiatives and strong financial position. In 2024, the company partnered with Motive Practicing Wisely Solutions to launch Amino Motivate, an accountable care organization optimization offering that combines physician performance analytics with consulting services. The company has also secured substantial funding, including $42 million in credit financing from Oxford Finance in July 2023 and $80 million in combined equity and debt financing led by Transformation Capital.
Capital Rx continues to innovate in the pharmacy benefit management space, having launched its Never More Again model in 2024, which enables self-funded plan sponsors to access preferred drug prices without requiring plan reimplementation or member disruption.
Click here for the original news story.